case series:Mecapegfilgrastim

3 trials

Sponsors

Fourth Hospital of Hebei Medical University, Harbin Institute of Hematology and Oncology; Cancer Center of the Whole Army of the Eastern Theater General hospital; Cancer Prevention and Treatment Center of Sun Yat-Sen University, Shanxi Tumor Hospital

Conditions

Chemotherapy-Induced NeutropeniaChemotherapy-related moderate or severe neutropeniaFebrile Neutropenia

Phase 4

A national multicenter real world study on the safety and efficacy of tiopefigeristine in the prevention of chemotherapy-related moderate to severe neutropenia in cancer patients

RecruitingChiCTR2000031768

Harbin Institute of Hematology and Oncology; Cancer Center of the Whole Army of the Eastern Theater General hospital; Cancer Prevention and Treatment Center of Sun Yat-Sen UniversityChemotherapy-related moderate or severe neutropenia

Start: 2020-04-10Updated: 2020-11-16

Prophylactic administration of mecapegfilgrastim after chemotherapy in patients with lymphoma

Active, not recruitingChiCTR2100048123

Shanxi Tumor HospitalFebrile Neutropenia

Start: 2018-01-01Updated: 2022-03-07

Unknown Phase

Study for Mecapegfilgrastim Prophylaxis/therapy of Chemotherapy-Induced Neutropenia in the Real-world

Active, not recruitingChiCTR1800020360

Fourth Hospital of Hebei Medical UniversityChemotherapy-Induced Neutropenia

Start: 2018-12-25Updated: 2019-01-14